161 related items for PubMed ID: 17199964
1. Tong-xie-ning, a Chinese herbal formula, in treatment of diarrhea-predominant irritable bowel syndrome: a prospective, randomized, double-blind, placebo-controlled trial.
Wang G, Li TQ, Wang L, Xia Q, Chang J, Zhang Y, Wan MH, Guo J, Cheng Y, Huang X, Zhang RM.
Chin Med J (Engl); 2006 Dec 20; 119(24):2114-9. PubMed ID: 17199964
[No Abstract] [Full Text] [Related]
2. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
Leung WK, Wu JC, Liang SM, Chan LS, Chan FK, Xie H, Fung SS, Hui AJ, Wong VW, Che CT, Sung JJ.
Am J Gastroenterol; 2006 Jul 20; 101(7):1574-80. PubMed ID: 16863563
[Abstract] [Full Text] [Related]
3. Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome.
Vahedi H, Merat S, Momtahen S, Kazzazi AS, Ghaffari N, Olfati G, Malekzadeh R.
Aliment Pharmacol Ther; 2008 Apr 20; 27(8):678-84. PubMed ID: 18248658
[Abstract] [Full Text] [Related]
4. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
Wang Y, Huang YQ, Zhu SL, Zhang CR, Chen XL, Hou QK, Liu FB.
Trials; 2020 Nov 03; 21(1):908. PubMed ID: 33143731
[Abstract] [Full Text] [Related]
5. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.
Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L.
Dig Liver Dis; 2007 Jun 03; 39(6):530-6. PubMed ID: 17420159
[Abstract] [Full Text] [Related]
6. Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial.
Tang XD, Lu B, Li ZH, Wei W, Meng LN, Li BS, Tang ZP, Gao R, Wang FY, Lu F, Bian LQ, Zhao YP, Wang P, Zhang YQ.
Chin J Integr Med; 2018 Sep 03; 24(9):645-652. PubMed ID: 27487786
[Abstract] [Full Text] [Related]
7. Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome.
Chen M, Tang TC, Wang Y, Shui J, Xiao XH, Lan X, Yu P, Zhang C, Wang SH, Yao J, Zheng H, Huang DQ.
Aliment Pharmacol Ther; 2018 Jul 03; 48(2):160-168. PubMed ID: 29856472
[Abstract] [Full Text] [Related]
8. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.
Chang FY, Lu CL, Chen CY, Luo JC.
J Gastroenterol Hepatol; 2007 Dec 03; 22(12):2266-72. PubMed ID: 17559369
[Abstract] [Full Text] [Related]
9. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
Leventer SM, Raudibaugh K, Frissora CL, Kassem N, Keogh JC, Phillips J, Mangel AW.
Aliment Pharmacol Ther; 2008 Jan 15; 27(2):197-206. PubMed ID: 17973974
[Abstract] [Full Text] [Related]
10. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
Tang XD, Zhang SS, Hou XH, Li ZH, Chen SN, Feng PM, Yang XN, Li HZ, Wu JQ, Xia PJ, Yang XJ, Zhou HJ, Wang HY, Ai YW, Li K.
Chin J Integr Med; 2019 Dec 15; 25(12):887-894. PubMed ID: 31292845
[Abstract] [Full Text] [Related]
11. Traditional Chinese medicine (Shun-Qi-Tong-Xie Granule) for irritable bowel syndrome: study protocol for a randomised controlled trial.
Wang XX, Luo RJ, She B, Chen Y, Guo J.
Trials; 2014 Jul 07; 15():273. PubMed ID: 25002196
[Abstract] [Full Text] [Related]
12. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.
Drossman DA, Danilewitz M, Naesdal J, Hwang C, Adler J, Silberg DG.
Am J Gastroenterol; 2008 Oct 07; 103(10):2562-9. PubMed ID: 18775020
[Abstract] [Full Text] [Related]
13. Tai-Kang-Ning, a Chinese herbal medicine formula, alleviates acute heroin withdrawal.
Kang L, Li B, Gao L, Li S, Wang D, Hu M, Li J.
Am J Drug Alcohol Abuse; 2008 Oct 07; 34(3):269-76. PubMed ID: 18428069
[Abstract] [Full Text] [Related]
14. [A multi-center randomized controlled trial on treatment of diarrhea-predominant irritable bowel syndrome by Chinese medicine syndrome-differentiation therapy].
Zhang SS, Wang HB, Li ZH.
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jan 07; 30(1):9-12. PubMed ID: 20353023
[Abstract] [Full Text] [Related]
15. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
Chey WD, Paré P, Viegas A, Ligozio G, Shetzline MA.
Am J Gastroenterol; 2008 May 07; 103(5):1217-25. PubMed ID: 18477346
[Abstract] [Full Text] [Related]
16. A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.
Krause R, Ameen V, Gordon SH, West M, Heath AT, Perschy T, Carter EG.
Am J Gastroenterol; 2007 Aug 07; 102(8):1709-19. PubMed ID: 17509028
[Abstract] [Full Text] [Related]
17. The efficacy of Shugan Jianpi Zhixie therapy for diarrhea-predominant irritable bowel syndrome: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Xiao Y, Liu Y, Huang S, Sun X, Tang Y, Cheng J, Wang T, Li F, Kuang Y, Luo R, Zhao X.
PLoS One; 2015 Aug 07; 10(4):e0122397. PubMed ID: 25853241
[Abstract] [Full Text] [Related]
18. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents.
Bahar RJ, Collins BS, Steinmetz B, Ament ME.
J Pediatr; 2008 May 07; 152(5):685-9. PubMed ID: 18410774
[Abstract] [Full Text] [Related]
19. Study on the clinical mechanism of Tong-Xie-An-Chang Decoction in the treatment of diarrheal irritable bowel syndrome based on single-cell sequencing technology.
Tan X, Zhao XJ, Li JX, Xie CE, Pei WJ, Shi L, Kou FS, Yuan YL, Xue XX.
Medicine (Baltimore); 2020 Dec 24; 99(52):e23868. PubMed ID: 33350782
[Abstract] [Full Text] [Related]
20. [Effects of Changjishu soft elastic capsule in treatment of diarrhea-predominant irritable bowel patients with liver-qi stagnation and spleen deficiency syndrome: a randomized double-blinded controlled trial].
Gao WY, Lin YF, Chen SQ, Lu YP, Yang Z, Gong Y, Liu Y, Wang LX, Wang CH.
Zhong Xi Yi Jie He Xue Bao; 2009 Mar 24; 7(3):212-7. PubMed ID: 19284948
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
